U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599085) titled 'Early Feasibility Study to Assess the Safety and Effectiveness of the OnePoint Dialysis CannulaTM as a Single-Site Vascular Access Device for Hemodialysis Procedures' on April 17.
Brief Summary: This is an early feasibility, pre-market, prospective, interventional, single-arm, non-randomized / open-label study intended to support a future pivotal IDE study for eventual FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
Study Start Date: Aug. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Vascular Access
Intervention:
DEVICE: ...